Time to first NSAID post index date stratified by CV-event diagnosis at

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

CKD risk for each additional cumulative month of NSAIDs exposure, based

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data - The Lancet

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Serum 25(OH)D Concentration, Vitamin D Supplementation, and Risk of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes or Prediabetes: a Systematic Review and Dose–Response Meta-Analysis - The American Journal of

Kaplan-Meier curves showing (A) time to first coronary

Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week - ScienceDirect

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study

Cardiovascular and Noncardiovascular Prescribing and Mortality After Takotsubo: Comparison With Myocardial Infarction and General Population

/cms/asset/bd0e5a7d-ad96-4ceb-a

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review

ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic by Dr Ammar Al-rajehe - Issuu

Jose HERNANDEZ, Associate Adjunct Professor

Simultaneous assessment of short‐term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: An instrumental variable analysis - Schneeweiss - 2006 - Arthritis